Lonza Group Ltd.

Lonza Group Ltd. is a leading global provider of integrated solutions for the pharmaceutical, biotech, and specialty ingredients markets. Established with a commitment to innovation and sustainability, Lonza operates in over 30 countries, delivering high-quality products and services that meet the evolving needs of its customers.

The company’s core activities include:

• Pharmaceuticals: Offering contract development and manufacturing services (CDMO) for drug substances and drug products.
• Biotechnology: Providing advanced biopharmaceutical manufacturing capabilities, including cell and gene therapies.
• Specialty Ingredients: Developing innovative solutions for consumer care, nutrition, and agriculture.

Lonza is dedicated to enhancing the quality of life through science and technology. The company invests significantly in research and development to drive innovation and improve operational efficiency. With a strong focus on sustainability, Lonza aims to minimize its environmental impact while maximizing the benefits of its products.

As a trusted partner to its clients, Lonza emphasizes collaboration and transparency, ensuring that it meets the highest standards of quality and compliance. The company’s vision is to be the most trusted partner in the life sciences industry, enabling its customers to bring their products to market faster and more efficiently.

Lonza’s commitment to excellence is reflected in its highly skilled workforce, which is dedicated to delivering superior results. By leveraging cutting-edge technologies and processes, Lonza continues to set benchmarks in the industry, making significant contributions to health and well-being worldwide.